ARTICLE | Clinical News
FluLaval Quadrivalent regulatory update
September 2, 2013 7:00 AM UTC
FDA approved FluLaval Quadrivalent influenza vaccine from GlaxoSmithKline to prevent seasonal influenza A and B infection in people >=3 years. GSK plans to make the intramuscular vaccine available for...